deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT06601179

Evaluating the Safety and Efficacy of the HIFU High-intensity Focused Ultrasound Treatment of Benign Prostatic Hyperplasia; (BPH EFFICACY)

Phase 1-2 Dose-escalation Study, Evaluating the Safety and Efficacy of the HIFU High-intensity Focused Ultrasound Treatment of Benign Prostatic Hyperplasia After 3 Months, 6 Months, 12 Months, 18 Months and 36 Months.

Sponsor: EDAP TMS S.A.

Conditions Benign Prostatic Hyperplasia
Interventions HIFU
Updated 2 times since 2024 Last updated: Oct 11, 2024 Started: Aug 23, 2024 Primary completion: Aug 31, 2028 Completion: Aug 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Benign Prostatic Hyperplasia and is currently actively recruiting participants. EDAP TMS S.A. leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshotRecruiting~Nov 2024 – present · 20 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Nov 2024 — Present [monthly]

    Recruiting NA

  2. Oct 2024 — Nov 2024 [monthly]

    Recruiting NA

    First recorded

Aug 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • EDAP TMS S.A.
Data source: EDAP TMS S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations